Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Atherosclerosis ; 228(2): 339-45, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23582588

RESUMEN

PURPOSE: The aim of this study was to compare the ability of (18)F-FDG PET and iron contrast-enhanced MRI with a novel USPIO (P904) to assess change in plaque inflammation induced by atorvastatin and dietary change in a rabbit model of atherosclerosis using a combined PET/MR scanner. MATERIALS AND METHODS: Atherosclerotic rabbits underwent USPIO-enhanced MRI and (18)F-FDG PET in PET/MR hybrid system at baseline and were then randomly divided into a progression group (high cholesterol diet) and a regression group (chow diet and atorvastatin). Each group was scanned again 6 months after baseline imaging. R2* (i.e. 1/T2*) values were calculated pre/post P904 injection. (18)F-FDG PET data were analyzed by averaging the mean Standard Uptake Value (SUVmean) over the abdominal aorta. The in vivo imaging was then correlated with matched histological sections stained for macrophages. RESULTS: (18)F-FDG PET showed strong FDG uptake in the abdominal aorta and P904 injection revealed an increase in R2* values in the aortic wall at baseline. At 6 months, SUVmean values measured in the regression group showed a significant decrease from baseline (p = 0.015). In comparison, progression group values remained constant (p = 0.681). R2* values showed a similar decreasing trend in the regression group suggesting less USPIO uptake in the aortic wall. Correlations between SUVmean or Change in R2* value and macrophages density (RAM-11 staining) were good (R(2) = 0.778 and 0.707 respectively). CONCLUSION: This experimental study confirms the possibility to combine two functional imaging modalities to assess changes in the inflammation of atherosclerotic plaques. (18)F-FDG-PET seems to be more sensitive than USPIO P904 to detect early changes in plaque inflammation.


Asunto(s)
Aorta Abdominal , Enfermedades de la Aorta/diagnóstico , Aterosclerosis/diagnóstico , Medios de Contraste , Dextranos , Fluorodesoxiglucosa F18 , Inflamación/diagnóstico , Imagen por Resonancia Magnética , Nanopartículas de Magnetita , Placa Aterosclerótica , Tomografía de Emisión de Positrones , Radiofármacos , Animales , Aorta Abdominal/diagnóstico por imagen , Aorta Abdominal/efectos de los fármacos , Aorta Abdominal/patología , Enfermedades de la Aorta/diagnóstico por imagen , Enfermedades de la Aorta/tratamiento farmacológico , Enfermedades de la Aorta/patología , Aterosclerosis/diagnóstico por imagen , Aterosclerosis/tratamiento farmacológico , Aterosclerosis/patología , Atorvastatina , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Ácidos Heptanoicos/farmacología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Inflamación/diagnóstico por imagen , Inflamación/tratamiento farmacológico , Inflamación/patología , Valor Predictivo de las Pruebas , Pirroles/farmacología , Conejos , Radiografía , Factores de Tiempo
2.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA